Subhabrata Ray

2.9k total citations · 1 hit paper
49 papers, 2.1k citations indexed

About

Subhabrata Ray is a scholar working on Pharmaceutical Science, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Subhabrata Ray has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmaceutical Science, 7 papers in Biomaterials and 6 papers in Biomedical Engineering. Recurrent topics in Subhabrata Ray's work include Advanced Drug Delivery Systems (14 papers), Drug Solubulity and Delivery Systems (12 papers) and Advancements in Transdermal Drug Delivery (12 papers). Subhabrata Ray is often cited by papers focused on Advanced Drug Delivery Systems (14 papers), Drug Solubulity and Delivery Systems (12 papers) and Advancements in Transdermal Drug Delivery (12 papers). Subhabrata Ray collaborates with scholars based in India, Germany and United States. Subhabrata Ray's co-authors include Swarupananda Mukherjee, F. Durst, Bhaskar Mazumder, Bülent Ünsal, A.W. Date, Paulami Pal, Satya P. Moulik, Ranjan Bhadra, Subramanian Natesan and Saroj K. Ghosal and has published in prestigious journals such as International Journal of Hydrogen Energy, International Journal of Heat and Mass Transfer and International Journal of Pharmaceutics.

In The Last Decade

Subhabrata Ray

49 papers receiving 2.0k citations

Hit Papers

Solid lipid nanoparticles... 2009 2026 2014 2020 2009 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subhabrata Ray India 21 757 466 341 314 306 49 2.1k
Guy Couarraze France 28 1.1k 1.4× 311 0.7× 346 1.0× 282 0.9× 184 0.6× 68 2.4k
Paola Russo Italy 35 736 1.0× 307 0.7× 432 1.3× 163 0.5× 254 0.8× 125 3.5k
Celine Valeria Liew Singapore 26 1.0k 1.4× 711 1.5× 272 0.8× 286 0.9× 333 1.1× 97 2.7k
Paul J. Sheskey United States 12 1.8k 2.3× 435 0.9× 229 0.7× 126 0.4× 166 0.5× 16 3.2k
Abina M. Crean Ireland 26 997 1.3× 375 0.8× 310 0.9× 118 0.4× 81 0.3× 70 2.0k
Philip Chi Lip Kwok Australia 32 666 0.9× 415 0.9× 515 1.5× 71 0.2× 144 0.5× 87 2.7k
Claudia S. Leopold Germany 26 1.0k 1.4× 167 0.4× 221 0.6× 148 0.5× 88 0.3× 92 1.9k
Hartwig Steckel Germany 29 880 1.2× 244 0.5× 370 1.1× 120 0.4× 212 0.7× 73 2.5k
Ingunn Tho Norway 31 1.2k 1.6× 370 0.8× 190 0.6× 111 0.4× 66 0.2× 78 2.1k
Kees van der Voort Maarschalk Netherlands 21 556 0.7× 491 1.1× 202 0.6× 281 0.9× 186 0.6× 48 2.1k

Countries citing papers authored by Subhabrata Ray

Since Specialization
Citations

This map shows the geographic impact of Subhabrata Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhabrata Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhabrata Ray more than expected).

Fields of papers citing papers by Subhabrata Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhabrata Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhabrata Ray. The network helps show where Subhabrata Ray may publish in the future.

Co-authorship network of co-authors of Subhabrata Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Subhabrata Ray. A scholar is included among the top collaborators of Subhabrata Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhabrata Ray. Subhabrata Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rahman, Mahfoozur, et al.. (2020). Insights into the Approach, Fabrication, Application, and Lacunae of Nanoemulsions in Drug Delivery Systems. Critical Reviews in Therapeutic Drug Carrier Systems. 37(6). 511–551. 5 indexed citations
3.
Ray, Subhabrata, et al.. (2019). Nano-emulgel: Emerging as a Smarter Topical Lipidic Emulsion-based Nanocarrier for Skin Healthcare Applications. Recent Patents on Anti-Infective Drug Discovery. 14(1). 16–35. 55 indexed citations
4.
Gupta, Purnima, et al.. (2019). Grape seed extract: having a potential health benefits. Journal of Food Science and Technology. 57(4). 1205–1215. 127 indexed citations
5.
Das, Pranab, et al.. (2018). Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery. European Journal of Ophthalmology. 29(1). 113–126. 64 indexed citations
6.
Chattopadhyay, Pronobesh, et al.. (2018). Aspects of Nanomaterials in Wound Healing. Current Drug Delivery. 16(1). 26–41. 46 indexed citations
7.
Ray, Subhabrata, et al.. (2017). Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam. Pharmaceutical Nanotechnology. 5(1). 32–43. 6 indexed citations
8.
Pal, Paulami, et al.. (2014). Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis. Drug Development and Industrial Pharmacy. 41(7). 1095–1099. 17 indexed citations
9.
Ghosh, Surajit Kumar, et al.. (2014). In vitro & in vivo Studies on Lornoxicam Loaded Nanoemulsion Gels for Topical Application. Current Drug Delivery. 11(1). 132–138. 28 indexed citations
10.
Ghosh, Surajit, et al.. (2013). Solid Lipid Nanoparticles (SLNs) Gels for Topical Delivery of Aceclofenac in vitro and in vivo Evaluation. Current Drug Delivery. 10(6). 656–666. 18 indexed citations
11.
Ray, Subhabrata, et al.. (2009). Drug-drug interactions in the ICU. Critical Care. 13(Suppl 1). P495–P495. 1 indexed citations
12.
Mukherjee, Swarupananda, et al.. (2009). Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Indian Journal of Pharmaceutical Sciences. 71(4). 349–349. 688 indexed citations breakdown →
13.
Patel, Asha, et al.. (2006). Invitro evaluation and optimization of controlled release floating drug delivery system of metformin hydrochloride. DARU Journal of Pharmaceutical Sciences. 14(2). 57–64. 51 indexed citations
15.
Ray, Subhabrata, et al.. (2006). Formulation and evaluation of mucoadhesive dosage form containing rosiglitazone maleate.. PubMed. 19(3). 208–13. 8 indexed citations
16.
Ray, Subhabrata & A.W. Date. (2001). Laminar flow and heat transfer through square duct with twisted tape insert. International Journal of Heat and Fluid Flow. 22(4). 460–472. 49 indexed citations
17.
Ray, Subhabrata, et al.. (2001). Preparation and in vitro dissolution of isoniazid from ethylcellulose microcapsules.. PubMed. 58(1). 65–8. 5 indexed citations
18.
Ray, Subhabrata, et al.. (2000). STATISTICAL OPTIMIZATION SUPPORTED PRODUCT DEVELOPMENT OF ANTI – ASTHAMATIC MULTIPARTICULATE DRUG DELIVERY SYSTEM. Indian Journal of Pharmaceutical Sciences. 62(3). 175–180. 2 indexed citations
19.
Ray, Subhabrata, et al.. (1999). In Vitro Release and Diffusion Studies of Promethazine Hydrochloride from Polymeric Dermatological Bases Using Cellulose Membrane and Hairless Mouse Skin. Drug Development and Industrial Pharmacy. 25(2). 235–240. 7 indexed citations
20.
Ray, Subhabrata, et al.. (1994). Development of a mutant strain of Aspergillus niger and optimization of some physical factors for improved calcium gluconate production.. PubMed. 32(12). 865–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026